Statistics
Publications
28
Citations
3K
H-Index
22
Active since
2006
Erik Bloomquist is an author at United States Food and Drug Administration specializing in oncology, medicine, and pharmacology.
Publications per year
2006–2024
28
28
Jennifer Gao, Joyce Cheng, Erik Bloomquist et al. · The Lancet Oncology · 2019 · 297 citations
Medicine, Oncology, Pharmacology +17
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors
Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 171 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 28